Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway(Providence College), H. Robert Brashear(Janssen (United States)), Lawrence S. Honig(Columbia University), Julia Lull(Janssen (United States)), Enchi Liu(University of Washington), Michael Grundman(University of San Diego), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Marcel Reichert(Veterans Health Administration), Kaj Blennow(Sahlgrenska University Hospital), Anton P. Porsteinsson(University of Rochester), William E. Klunk(University of Pittsburgh), Eric Yuen(Janssen (United States)), Iulia Cristina Tudor(Janssen (United States)), Murray A. Raskind(University of Washington), Nzeera Ketter(Janssen (United States)), Maja Miloslavsky(Janssen (United States)), Bijan Nejadnik(Janssen (United States)), Daniel Wang(Vanderbilt University Medical Center), Yuan Lü(Jazz Pharmaceuticals (United States)), Marwan N. Sabbagh(Cleveland Clinic), Ronald S. Black(Pfizer (United States)), Reisa A. Sperling(Brigham and Women's Hospital), Volkmar Guenzler(Janssen (United States)), Steven H. Ferris(NYU Langone Health)
Cited by 1,966
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k